China NMPA Inspection - Wuhan Wujing Pharmaceutical Co., Ltd. - August 26, 2016
China NMPA unannounced inspection for Wuhan Wujing Pharmaceutical Co., Ltd. published August 26, 2016. Wuhan Wujing Pharmaceutical Co., Ltd. was subjected to an unannounced follow-up inspection by the China Food and Drug Administration (CFDA) from April
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Wuhan Wujing Pharmaceutical Co., Ltd. published August 26, 2016. Wuhan Wujing Pharmaceutical Co., Ltd. was subjected to an unannounced follow-up inspection by the China Food and Drug Administration (CFDA) from April
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
Drugs
ID: 3b41929b-38b0-4c44-b9f3-d79159d74167
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox